Myocardial Infarction

This publication has 13 references indexed in Scilit:

• Effect of verapamil on mortality and major events after acute myocardial infarction (The Danish Verapamil Infarction Trial II — DAVIT II)
  The American Journal of Cardiology, 1990
• Retardation of angiographic progression of coronary artery disease by nifedipine
  The Lancet, 1990
• The Effect of Diltiazem on Mortality and Reinfarction after Myocardial Infarction
  New England Journal of Medicine, 1988
• Secondary prevention reinfarction Israeli nifedipine trial (SPRINT). A randomized intervention trial of nifedipine in patients with acute myocardial infarction. The Israeli Sprint Study Group.
  1988
• Nifedipine in acute myocardial infarction: an assessment of left ventricular function, infarct size, and infarct expansion. A double blind, randomised, placebo controlled trial.
  Heart, 1988
• Early treatment of unstable angina in the coronary care unit: a randomised, double blind, placebo controlled comparison of recurrent ischaemia in patients treated with nifedipine or metoprolol or both. Report of The Holland Interuniversity Nifedipine/Metoprolol Trial (HINT) Research Group.
  Heart, 1986
• Why Ca2$ antagonists will be most useful before or during early myocardial ischaemia and not after infarction has been established
  European Heart Journal, 1986
• Angiographic evolution of coronary artery morphology in unstable angina
  Journal of the American College of Cardiology, 1986
• Evolution of infarct size during the early use of nifedipine in patients with acute myocardial infarction: the Norwegian Nifedipine Multicenter Trial.
  Circulation, 1984
• Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison.
  Circulation, 1984